Diabetes

US FDA approves expanded use of Sanofi’s Type 1 diabetes drug in children aged 8 to 17

The FDA first approved Tzield in 2022.

Asian Insider

Battling the bulge jab by jab: India’s weight-loss drugs now within the reach of millions

Bengaluru-based food consultant Monika Manchanda, 50, spoke of the weight loss drug as offering a mental break from a years-long worry.

GLP-1 drugs may have a beneficial effect across many types of cancer

FILE PHOTO: A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo

Fatty liver genes combined with diabetes and obesity increase liver cancer risk: S’pore study

Adj A/Prof Daniel Huang, Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH and Chair of the Hepato-Pancreato-Biliary Cancer Programme at NCIS, with his patient Mr Foo Say Nong at NUH Medical Centre on May 25, 2026.

Growing number of liver transplant patients linked to obesity and diabetes, instead of hepatitis B

Lian Pooh Kim, 60, who underwent a liver transplant in 2024, pictured at their home on March 27, 2026.

US FDA approves new insulin injection for Type 2 diabetes

Novo Nordisk's new product reduces injections from seven to one a week.

Commentary

Singapore crosses the super-aged threshold in 2026. Can its health system cope?

In 2026, Singapore will cross a demographic threshold that few countries have reached as rapidly, becoming a super-aged society, where at least 21 per cent of the population is aged 65 and above

Zverev plays 'two games at once' as diabetes clock ticks under Australian Open run

Jan 25, 2026; Melbourne, Victoria, Australia; Alexander Zverev of Germany in action against Francisco Cerundolo of Argentina in the fourth round of the men’s singles at the Australian Open at John Cain Arena in Melbourne Park. Mandatory Credit: Mike Frey-Imagn Images

S’pore study finds new way to disarm antibiotic-resistant bacteria, hasten healing of chronic wounds

The team of scientists, led by NTU Associate Professor Guillaume Thibault (left), included visiting professor at the Singapore Centre for Environmental Life Sciences and Engineering (SCELSE) Kimberly Kline from the University of Geneva (centre) and NTU Research Fellow, Dr Aaron Tan.
Credit: NTU

Thai FDA seeks to tighten controls on GLP-1 ‘slimming pens’, proposing special controlled-drug status

Thailand’s FDA is seeking to reclassify GLP-1 weight-loss injection pens as a special controlled drug, limiting sales to pharmacies with a doctor’s prescription amid misuse online.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.